Cleft lip and palate transmembrane protein 1-like protein, CLPTM1-like protein, Cisplatin resistance-related protein 9, CRR9p, CLPTM1L, CRR9
Product description
CLPTM1L enhances cisplatin-mediated apoptosis, when overexpressed.1) Liu, Z., et al. Carcinogenesis 31(11):1977-1981(2010) Hsiung, C.A., et al. PLoS Genet.(8) (2010)Truong, T., et al. J. Natl. Cancer Inst. 102(13):959-971(2010) Pooley, K.A., et al. Cancer Epidemiol. Biomarkers Prev. 19(7):1862-1865(2010) Turnbull, C., et al. Nat. Genet. 42(7):604-607(2010)
Immunogen
This CLPTM1L antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 370-399 amino acids from the C-terminal region of human CLPTM1L.
Western blot analysis in A549 cell line lysates (35ug/lane).
Application Notes
For WB starting dilution is: 1:1000:
Additional Information
Form
Liquid
Storage Instructions
Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.